Literature DB >> 23739935

Analysis of left ventricular function in patients with heart failure undergoing cardiac resynchronization.

Ricardo Adala Benfatti1, Felipe Matsushita Manzano, José Carlos Dorsa Vieira Pontes, Amaury Edgardo Mont'serrat Ávila Souza Dias, João Jackson Duarte, Guilherme Viotto Rodrigues da Silva, Jandir Ferreira Gomes Junior, Neimar Gardenal.   

Abstract

BACKGROUND: The gold standard surgical treatment for heart failure is cardiac transplantation, however, due to difficulties of this treatment, other surgical proposals have been reported, including the implantation of cardiac resynchronizer.
OBJECTIVE: To analyze the left ventricular function by echocardiography in patients with advanced heart failure with interventricular dyssynchrony undergone implantation of cardiac resynchronizer.
METHODS: Between June 2006 and June 2012, 24 patients with average age of 61.5 ± 11 years were evaluated, carriers of advanced congestive heart failure functional class III and IV (NYHA), interventricular dyssynchrony and optimal drug therapy, and submitted implantation of cardiac resynchronizer and postoperative echocardiographically evaluated in six months.
RESULTS: There was significant improvement of the analyzed echocardiography parameters. The average left ventricular diastolic diameter decreased from 69.6 ± 9.8 mm to 66.8 ± 8.8 mm, systolic diameters from 58.6 ± 8.8 mm to 52.7 ± 8.8 mm, and ejection fraction, average of 31 ± 8% to 40 ± 7% with level of significance, respectively, of 0.019, 0.0004 and 0.0002, statistically significant with a significance level of 0.05.
CONCLUSION: There was a significant improvement of left ventricular function analyzed by echocardiography at six months, in patients with advanced heart failure undergone implantation of cardiac resynchronizer.

Entities:  

Mesh:

Year:  2013        PMID: 23739935     DOI: 10.5935/1678-9741.20130011

Source DB:  PubMed          Journal:  Rev Bras Cir Cardiovasc


  2 in total

1.  Geniposide from Gardenia jasminoides var. radicans Makino Attenuates Myocardial Injury in Spontaneously Hypertensive Rats via Regulating Apoptotic and Energy Metabolism Signalling Pathway.

Authors:  Ying Hou; Peipei Yuan; Yang Fu; Qi Zhang; Liyuan Gao; Yaxin Wei; Xiaoke Zheng; Weisheng Feng
Journal:  Drug Des Devel Ther       Date:  2021-03-03       Impact factor: 4.162

2.  Analysis of Dyssynchrony and Ventricular Function in Right Univentricular Stimulation at Different Positions.

Authors:  Ana Paula Susin Osório; Stefan Warpechowski; Antonio Lessa Gaudie Ley; Marcelo Haertel Miglioranza; Laura Lessa Gaudie Ley; Eduardo Dytz Almeida; Roberto Tofani Sant'anna; Tiago Luiz Luz Leiria
Journal:  Braz J Cardiovasc Surg       Date:  2017 Nov-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.